# Apnimed, Inc. Common Stock (APMD)

> Apnimed, Inc. Common Stock (APMD) trades at $17.35 (-2.53%) as of 7:48:47 PM EST on Nov 18, 2026, -5.73% over the past month. Market cap is $726.46M, with 4.5 days to cover in short interest.

Canonical: https://massive.com/quote/apmd
Data as of: 2026-11-19T00:48:47.685Z (15-minute delayed)
Source: Massive (https://massive.com/docs/llms.txt)

## Price

**$17.35** -0.45 (-2.53%)
As of 7:48:47 PM EST on Nov 18, 2026 · 15-minute delayed
Nasdaq · usd

## Stock performance

How Apnimed, Inc. Common Stock (APMD) stock has performed from one day to one year, with its 52-week range.

| Period | Return |
| --- | --- |
| 1D | -1.97% |
| 1W | +3.99% |
| 1M | -5.73% |
| YTD | -30.20% |
| 1Y | -30.20% |
| 52-wk range | $13.88 – $35.29 |

From daily closes through Nov 18, 2026.

## Key statistics

Today's trading snapshot for APMD: day range, open, previous close, volume and market cap.

| Measure | Value |
| --- | --- |
| Day range | $17.41 – $19.06 |
| Open | $17.87 |
| Prev close | $17.80 |
| Volume | 297.63K |
| Market cap | $726.46M |
| Shares out | 41.63M |

## Insider trading

[Apnimed, Inc. Common Stock (APMD) insider trading](https://massive.com/quote/apmd/insider-trading.md): open-market Form 4 buys and sells by Apnimed, Inc. Common Stock insiders over the last 12 months.

## 8-K filings

Material corporate events Apnimed, Inc. Common Stock has disclosed to the SEC on Form 8-K.

- Nov 13, 2026 · [Financial restatement](https://massive.com/quote/sec-filings/8-k/restatements.md)
  “The Audit Committee ... concluded that the Company's previously issued financial statements ... should no longer be relied upon due to an error identified in the classification of the gain on the disposition of the Company's equity method investment in ... SASS for the three and six months ended June 30, 2026 as a gain in continuing operations rather than discontinued operations.”
- Sep 8, 2026 · [Quarterly earnings](https://massive.com/quote/sec-filings/8-k/earnings-releases.md)
  “On September 8, 2026, Apnimed, Inc. issued a press release announcing its financial results for the quarterly period ended June 30, 2026.”
- Aug 3, 2026 · Charter amendment
  “on August 3, 2026, the Company filed its ninth amended and restated certificate of incorporation (the "Restated Certificate") with the Secretary of State of the State of Delaware... The Restated Certificate amends and restates the Company's existing eighth amended and restated certificate of incorporation, as amended, in its entirety to, among other things: (i) authorize 500,000,000 shares of common stock and (ii) eliminate all references to the previously existing series of preferred stock; and (iii) authorize 10,000,000 shares of undesignated preferred stock that may be issued from time to time by the Board in one or more series.”

## APMD short interest

How heavily APMD is shorted: shares short, days to cover and average daily volume.

| Measure | Value |
| --- | --- |
| Days to cover | 4.5 |
| Short interest | 1.59M |
| Avg volume | 349.28K |

As of Oct 30, 2026 · reported to FINRA twice monthly.

## APMD news

The latest news and headlines about Apnimed, Inc. Common Stock (APMD).

- [Obstructive Sleep Apnea Clinical Trial and Competitive Landscape Expands as 18+ Leading Companies Accelerate Drug Development \| DelveInsight](https://www.globenewswire.com/news-release/2026/10/29/3391721/0/en/obstructive-sleep-apnea-clinical-trial-and-competitive-landscape-expands-as-18-leading-companies-accelerate-drug-development-delveinsight.html) · GlobeNewswire Inc. · Oct 29, 2026 · positive sentiment
- [Apnimed Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares](https://www.globenewswire.com/news-release/2026/08/03/3337925/0/en/Apnimed-Announces-Closing-of-Upsized-Initial-Public-Offering-Including-Full-Exercise-of-Underwriters-Option-to-Purchase-Additional-Shares.html) · GlobeNewswire Inc. · Aug 3, 2026 · positive sentiment

## About Apnimed, Inc. Common Stock

Apnimed Inc is a late clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of novel oral therapies that address the neurobiology of sleep related breathing diseases. The company's flagship product candidate, AD109, or Oxnimbi, is an investigational, fixed-dose oral combination of a novel anti-muscarinic and selective norepinephrine reuptake inhibitor for the treatment of obstructive sleep apnea (OSA).

| Measure | Value |
| --- | --- |
| Exchange | Nasdaq |
| Market | stocks |
| Type | CS |
| Currency | USD |
| Industry | PHARMACEUTICAL PREPARATIONS |
| IPO | $16.00 on Jul 31, 2026 |

[Apnimed IPO page](https://massive.com/quote/apmd/ipo.md)

[Company website](https://www.apnimed.com)

## FAQ

### What is the Apnimed, Inc. Common Stock (APMD) stock price today?

Apnimed, Inc. Common Stock (APMD) is trading at $17.35 (-2.53% on the day) as of 7:48:47 PM EST on Nov 18, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

### What is Apnimed, Inc. Common Stock?

Apnimed Inc is a late clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of novel oral therapies that address the neurobiology of sleep related breathing diseases.

### What is the short interest in APMD?

As of Oct 30, 2026, APMD has 1.59M shares short and 4.5 days to cover.

### What exchange is APMD listed on?

Apnimed, Inc. Common Stock (APMD) trades on Nasdaq in USD, in the PHARMACEUTICAL PREPARATIONS industry.

## Live data

Prices here are 15-minute delayed. For real-time APMD quotes and the full history behind this page, use the Massive API or MCP server:

- `GET https://api.massive.com/v3/snapshot?ticker.any_of=APMD`

Requests need a Massive API key. API reference for agents: https://massive.com/docs/llms.txt. Connect an AI agent through the Massive MCP server: https://massive.com/docs/ai-tools.

## Related

- [Apnimed, Inc. Common Stock (APMD) insider trading](https://massive.com/quote/apmd/insider-trading.md)
- [SEC 8-K events](https://massive.com/quote/sec-filings/8-k.md)
- [Markets overview](https://massive.com/quote/index.md)

Nothing here is investment advice. Data and content are provided for informational purposes under the Massive Terms of Service: https://massive.com/terms
